Correspondence 0001213900-24-007480 from REVELATION BIOSCIENCES, INC. (REVB)
REVELATION BIOSCIENCES, INC.
Date: Jan. 29, 2024 · CIK: 0001810560 · Accession: 0001213900-24-007480
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276232
Referenced dates: January 2, 2024
Letter
J.P. Galda & Co.
Attorneys-at-Law
40 Montgomery Avenue, LTW 220
Ardmore, Pennsylvania 19003
Telephone (215) 815-1534
January 29, 2024
Via EDGAR
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attention: Cindy Polynice
Laura Crotty
Re: Revelation Biosciences, Inc.
Registration Statement on Form S-1
File Number 333-276232
Mesdames Polynice and Crotty:
Today Revelation Biosciences, Inc. (the “Company”) has filed Amendment No. 1 to its Registration Statement on Form S-1 to respond to the staff's letter of comments dated January 2, 2024 (the “Comment Letter”), to reflect the effects of a 1 for 30 reverse stock split which was effective as of January 25, 2024, and to include the number of warrants and prefunded warrants to be registered. The numbered paragraphs below correspond to the numbered comments in the Comment Letter.
1. The cover page has been revised to state the date on which the offering will be terminated (25 days after the effective date of the registration statement).
2. The number of warrants and prefunded warrants (as well as the number of shares of common stock underlying the warrants and the pre-funded warrants) has been completed.
As I discussed on the telephone with Ms. Polynice, the Company will be requesting acceleration of effectiveness as soon as the Staff confirms that there are no further comments.
Please call or email with any further questions or comments.
Very truly yours,
/s/ Joseph P. Galda
Show Raw Text
CORRESP
1
filename1.htm
J.P. Galda & Co.
Attorneys-at-Law
40 Montgomery Avenue, LTW 220
Ardmore, Pennsylvania 19003
Telephone (215) 815-1534
January 29, 2024
Via EDGAR
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attention:
Cindy Polynice
Laura Crotty
Re: Revelation Biosciences, Inc.
Registration Statement on Form S-1
File Number 333-276232
Mesdames Polynice and Crotty:
Today Revelation Biosciences, Inc. (the “Company”)
has filed Amendment No. 1 to its Registration Statement on Form S-1 to respond to the staff's letter of comments dated January 2, 2024
(the “Comment Letter”), to reflect the effects of a 1 for 30 reverse stock split which was effective as of January 25, 2024,
and to include the number of warrants and prefunded warrants to be registered. The numbered paragraphs below correspond to the numbered
comments in the Comment Letter.
1. The cover page has been revised to state the date on which the offering will be terminated (25 days after the effective date of the
registration statement).
2. The number of warrants and prefunded warrants (as well as the number of shares of common stock underlying the warrants and the pre-funded
warrants) has been completed.
As I discussed on the telephone with Ms. Polynice,
the Company will be requesting acceleration of effectiveness as soon as the Staff confirms that there are no further comments.
Please call or email with any further questions or
comments.
Very truly yours,
/s/ Joseph P. Galda